Tuesday, November 23, 2021 12:52:34 PM
Nope, I never mentioned <85yo. The 154% efficacy is for patients with a CRP<150mg/L. When <85yo is added in, efficacy climbs to 2.96-fold/196% efficacy.
Nope, the 3.04-fold/204% efficacy on primary endpoint and 2.22-fold/122% efficacy on mortality are for patients with CRP<150mg/L + <85yo combined with remdesivir and steroids.
So patients with CRP<150mg/L had 154% efficacy on the primary endpoint. Efficacy rose to 196% efficacy for patients with CRP<150mg/L and <85yo. Efficacy rose to 204% efficacy for patients with CRP<150mg/L and <85yo and on remdesivir and steroids.
I solely showed 154% efficacy for patients with CRP<150mg/L because it is game-changing efficacy without complicating it by adding age requirements and other drugs.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM